Recent advances for cancer detection and treatment by microfluidic technology, review and update, Biological Procedures Online

Numerous cancer-associated deaths are owing to a lack of effective diagnostic and therapeutic approaches. Microfluidic systems for analyzing a low volume of samples offer a precise, quick, and user-friendly technique for cancer diagnosis and treatment. Microfluidic devices can detect many cancer-diagnostic factors from biological fluids and also generate appropriate nanoparticles for drug delivery. Thus, microfluidics may be valuable in the cancer field due to its high sensitivity, high throughput, and low cost. In the present article, we aim to review recent achievements in the application of microfluidic systems for the diagnosis and treatment of various cancers. Although microfluidic platforms are not yet used in the clinic, they are expected to become the main technology for cancer diagnosis and treatment. Microfluidic systems are proving to be more sensitive and accurate for the detection of cancer biomarkers and therapeutic strategies than common assays. Microfluidic lab-on-a-chip platforms have shown remarkable potential in the designing of novel procedures for cancer detection, therapy, and disease follow-up as well as the development of new drug delivery systems for cancer treatment.

A simple, low cost and reusable microfluidic gradient strategy and its application in modeling cancer invasion

Application of microfluidic technology based on surface-enhanced Raman scattering in cancer biomarker detection: A review - ScienceDirect

Micromachines, Free Full-Text

Nanotechnology and COVID-19 diagnosis and treatment

Recent advances in microfluidic technologies for circulating tumor cells: enrichment, single-cell analysis, and liquid biopsy for clinical application - Lab on a Chip (RSC Publishing) DOI:10.1039/D0LC00577K